Clinical trial · Interventional
Meridian Energy Changes of Head and Neck Cancer Patients After Chemotherapy or Radiotherapy
Detecting Changes Before and After Chemotherapy or Radiotherapy in Patients With Head and Neck Cancer by Meridian Electroacupuncture Analysis Device (MEAD)
NCT04872517CI-TRIAL-00069389unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This trial is conducted by using MEAD to detect the meridian changes in patients with head and neck cancer after conventional treatment of chemotherapy or radiotherapy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Cancer | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Meridian Electroacupuncture Analysis Device (MEAD) | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- 34 head and neck cancer patients, expected to proceed chemotherapy or radiotherapy in hospital.
- description
- Total 34 anticipants will recruit in this research. Age was limited between 20years old to 75 years old. All of anticipants agree to join this trail and be followed through treatment , and without underlying disease that threaten life.
- interventionNames
- Device: Meridian Electroacupuncture Analysis Device (MEAD)
Primary outcomes (1)
- measure
- meridian energy
- timeFrame
- An average of 6 weeks
- description
- energy change in meridian
Secondary outcomes (5)
- measure
- the number of participants with blood test data abnormal
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: 1. patients with head and neck cancer, included nasopharyngeal carcinoma, laryngeal cancer, oropharyngeal cancer, ear and oral cancer, hypopharyngeal cancer, salivary-gland carcinoma. Aged between 20 years old to 75years old, no gender difference. 2. patients with head and neck cancer has not received surgery yet, and will plan to accept chemotherapy and/or radiotherapy. 3. recurrent head and neck cancer, and expect to received chemotherapy and/or radiotherapy. 4. patient with vital sings stableness, conscious clear, and have ability to recognize the contain of trail and sign consent. 5. not accept other adjuvant therapy. 6. no brain metastasis or psychosis, and will to join whole course as well as accept assessments. Exclusion Criteria: 1. Aged less than 20 years old and over 75 years old。 2. Patients be diagnosed with head and neck cancer, and accepted surgery, or already finished chemotherapy and/or radiotherapy. 3. patient with brain metastasis, conscious unclear, and have not able to recognize the contain of trail and sign consent. 4. Accept other adjuvant therapy and chemotherapy and/or radiotherapy simultaneously. 5. Combined with serious organs failure。 6. Have contraindication in chemotherapy or radiotherapy.
References
Publications (0)
Data not yet available
No reference posted for this study.